Who Owns Odyssey Therapeutics Stock?
NASDAQ: ODTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 89.09%
- Held by insiders
- 6.19%
- Institutional holders
- 94
- Institutions 89.1%
- Insiders 6.2%
- Public and other 4.7%
Who owns Odyssey Therapeutics stock?
Institutional investors own about 89.1% of Odyssey Therapeutics's shares, spread across 94 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 6.19% of ODTX.
The largest institutional holders are FMR, LLC (12.98%), SR One Capital Management, LP (7.89%) and TPG GP A, LLC (7.68%). Together, the top 10 institutions control 53.9% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their ODTX positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ODTX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 6.24M | 12.98% | +20.5% |
| SR One Capital Management, LP | 3.79M | 7.89% | +100.0% |
| TPG GP A, LLC | 3.69M | 7.68% | +100.0% |
| Lightspeed Management Company, L.L.C. | 3.61M | 7.51% | +100.0% |
| Orbimed Advisors LLC. | 3.00M | 6.24% | +100.0% |
| Sanofi | 1.99M | 4.14% | -0.1% |
| Deerfield Management Company, L.P | 1.05M | 2.18% | +100.0% |
| Sands Capital Alternatives, LLC | 875.00K | 1.82% | +100.0% |
| HHLR Advisors, LTD | 831.66K | 1.73% | +100.0% |
| General Catalyst Group Management, LLC | 810.27K | 1.69% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ODTX
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 1.18M | 2.45% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 531.10K | 1.10% |
| iShares Trust-iShares Russell 2000 ETF | 424.68K | 0.88% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 349.20K | 0.73% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 329.06K | 0.68% |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 284.00K | 0.59% |
| T. Rowe Price Health Sciences Fund, Inc. | 182.55K | 0.38% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 179.66K | 0.37% |
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 99.83K | 0.21% |
| iShares Trust-iShares Russell 2000 Growth ETF | 91.63K | 0.19% |
Frequently asked questions
Who is the largest shareholder of Odyssey Therapeutics?
FMR, LLC is the largest institutional shareholder of ODTX, owning 12.98% of shares outstanding (6.24M shares) as of its latest 13F filing.
What percentage of Odyssey Therapeutics is owned by institutions?
Institutions own about 89.1% of ODTX shares and 95.0% of the public float.
How much of Odyssey Therapeutics do insiders own?
Insiders, such as officers and directors, own about 6.19% of ODTX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.